<DOC>
	<DOCNO>NCT03026452</DOCNO>
	<brief_summary>To evaluate safety efficacy ultrasonography ( US ) -guided radiofrequency ablation liver tumor , investigator use preoperative postoperative US/CEUS ( contrast-enhanced ultrasonography ) /CT/MRI assess lesion , laboratory test include tumor marker evaluate general condition patient . Intraoperative US/CEUS/CT would apply monitor ablation lesion .</brief_summary>
	<brief_title>Effectivity Safety Ultrasound-guided Percutaneously Radiofrequency Ablation Liver Cancer</brief_title>
	<detailed_description />
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Patients small hepatocellular carcinoma ( single multiple nodule less 3 cm diameter ) , Patients ChildPugh A/B , Patients PLT ( platelet count ) ≥ 50*10e9/L PT ( prothrombin time ) ≤ 20 . Patients blood coagulation dysfunction , ChildPugh score≥3 , severe cardiopulmonary disease , intolerant anesthesia upper gastrointestinal bleeding shock .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>